findings on May 19 * Abbott shares down 1 percent WASHINGTON, April 25 (Reuters) - A study of Abbott Laboratories' (ABT.N However, the clinical significance of the finding was unclear, the U.S. Food and Drug Administration said. An FDA advisory committee...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-Fibrate, statin combo may hurt females -US study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account